Analytical Challenges in Clinical Cancer Diagnostics by NGS

5:30 pm on Monday, April 28, 2014
7:00 pm on Monday, April 28, 2014
Doron Lipson, PhD Senior Director, Computational Biology Methods at Foundation Medicine in Cambridge Dr. Lipson has over 10 years of experience in developing genomic applications. He is currently leading a team responsible for developing clinical-grade computational methods for detecting driver alterations in tumors from NGS data at Foundation Medicine. Previously, he has worked at Helicos BioSciences and at Agilent, and was a co-founder of ProteOptics, which was acquired by Bio-Rad in 2006. Dr. Lipson received his Ph.D. in Computer Science from Israel Institute of Technology, and his B.S. in Computer Science and Biology from the Hebrew University of Jerusalem.